The treatment of burns and other injuries requiring skin grafts is slated for significant improvements following a world-first innovation by researchers at Metro North Health and UQ’s Frazer Institute.
The breakthrough is the development of a complete skin replica containing blood vessels and immune cells. By incorporating these critical components, the model more closely replicates real human skin, allowing researchers to better study wound healing, inflammation, infection, and gain insight into how patients may respond to treatments before they attend a clinic.
Stem cells were used to successfully grow a ‘replica’ of human skin, known as skin organoids, complete with all skin layers. These include hair follicles, sebaceous glands, pigmentation, and nerves, and now, blood vessels, capillaries and immune cells.
“Advancements in stem cell research have enabled us to grow mini versions of skin by taking human skin cells and reprogramming them into induced pluripotent stem cells*, which can be turned into almost any type of cell in the body,” explains Dr Abbas Shafiee, UQ Frazer Institute Researcher and Metro North Health Practitioner.
“We used these same stem cells to create vascular organoids, tiny living networks of blood vessels, and added these into the growing skin organoids to generate vascularised skin organoids.”
Transforming understanding of human skin development
Dr Shafiee said the research is an exciting step forward that will transform researchers’ understanding of human skin development, wound healing, inflammatory skin diseases, and future regenerative treatments.
“For many years, recreating the complexity of real human skin, particularly the integration of blood vessels, has been a significant challenge. Bringing together advances in stem cell biology, vascular biology, and organoid engineering developed over many years of research is what made our innovation possible.”
Skin graft transplants transformed by innovation
“Looking ahead, having these skin replica for research will transform how we study skin diseases and develop new therapies. In the longer term, they have the potential to revolutionise skin graft transplants and regenerative medicine, particularly for patients with severe burns, chronic wounds and genetic skin disorders.
“Unlike traditional biological skin models, our skin organoids closely mimic the structure of real human skin, including blood vessels and immune cells. This is critical, as successful skin grafting relies on how well transplanted skin integrates with the patient’s body, establishing blood supply, responding to inflammation and resisting infection.
“Our model allows the study of living human skin in ways that were not previously possible,” Dr Shafiee said.
“The skin organoids can grow and change over time in the laboratory. This enables us to study how human skin develops, how diseases emerge and progress, and how different treatments affect skin function over time.”
Learnings from this research could be used to accelerate the development of new treatments for skin wounds, and the next generation of skin grafts.
“Burns and treating burns is complex. There are so many variables in terms of how a burn will behave, likelihood of infection, extent of scarring, frequency/volume of skin grafts and revision surgery – as well as longer term complications such as chronic inflammation before skin ‘products’ are considered safe and reliable.
“Our technology changes that by providing a more predictive platform for developing new therapies before they are tested in patients.”
Dr Shafiee said that previously when researchers wanted to study skin, animals, particularly rodents, were used to study skin biology and test treatments. While valuable, rodent skin differs from human skin in structure, composition, immune response, healing processes and hair follicle biology, limiting how well findings translate to patients.
The Burns Registry of Australia and New Zealand for example records around 3,000 major burns admissions annually. Of these, approximately 70% of adult patients and over 50% of paediatric patients who undergo surgical wound procedures require skin grafts.
“This skin model will enable us to further progress those treatments, along with wound healing, regenerative medicine and precision dermatology by providing a more realistic human platform for testing therapies and understanding diseases. At the same time, we are continuing to improve the functionality of our skin organoid models.”
A new generation of research and regenerative therapies
Achieving the successful integration of blood supply and immune cells to this skin model was a six-year undertaking**.
While this innovation is already providing new opportunities to study human skin development, its use as a therapeutic skin graft for patients is still some years away.
“The possibilities are incredibly exciting,” Dr Shafiee says. “This breakthrough opens the door to a new generation of research and regenerative therapies, and it is a space worth watching closely in the years ahead.”
Further information
The research received funding from Metro North Health and was conducted at the Translational Research Institute.
- Vascularised skin replica model
- Skin replica model developed before the vascularised version:
*Pluripotent stem cells are remarkable cells that can continuously renew themselves and develop into almost any cell type in the human body. This unique ability makes them a powerful tool for researchers seeking to understand embryonic development, uncover disease mechanisms, and develop new treatments.
**Team members included Jane Sun, and Mitchell Mostina, who were Research Assistant and PhD candidate, respectively, at the time of this discovery. The study was co-led by Professor Kiarash Khosrotehrani, a clinician scientist and dermatologist at the UQ Frazer Institute.

